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OBJECTIVES The purpose of this study was to correlate angiographic and intravascular ultrasound (IVUS)
findings in left main coronary artery (LMCA) disease and identify the predictors of coronary
events at one year in patients with LMCA stenoses.
BACKGROUND Significant ($50% diameter stenosis [DS]) LMCA disease has a poor long-term prognosis.
METHODS One hundred twenty-two patients who underwent angiographic and IVUS assessment of the
severity of LMCA disease and who did not have subsequent catheter or surgical intervention
were followed for one year. Standard clinical, angiographic and IVUS parameters were
collected.
RESULTS The quantitative coronary angiography (QCA) reference diameter (3.91 6 0.76 mm, mean 6
1 SD) correlated moderately with IVUS (4.25 6 0.78 mm, r 5 0.492, p 5 0.0001). The
lesion site minimum lumen diameter (MLD) (2.26 6 0.82 mm) by QCA correlated less well
with IVUS (2.8 6 0.82 mm, r 5 0.364, p 5 0.0005). The QCA DS measured 42 6 16%.
During the follow-up period, 4 patients died, none had a myocardial infarction, 3 underwent
catheter-based LMCA intervention and 11 underwent bypass surgery. Univariate predictors
of events (p , 0.05) were diabetes, presence of another lesion whether treated with
catheter-based intervention or untreated with DS . 50% and IVUS reference plaque burden
and lesion lumen area, maximum lumen diameter, MLD, plaque area and area stenosis. Using
logistic regression analysis diabetes mellitus, an untreated vessel (with a DS . 50%) and
IVUS MLD were independent predictors of cardiac events.
CONCLUSIONS In selected patients assessed by IVUS, moderate LMCA disease had a one-year event rate of
only 14%. Intravascular ultrasound MLD was the most important quantitative predictor of
cardiac events. For any given MLD, the event rate was exaggerated in the presence of diabetes
or another untreated lesion (.50% DS). (J Am Coll Cardiol 1999;34:707–15) © 1999 by the
American College of Cardiology
Patients with significant ($50% diameter stenosis [DS])
left main coronary artery (LMCA) disease are known to
have a poor long-term prognosis (1–10). However, the
prognosis of patients with mild to moderate (,50% DS)
LMCA narrowing is still unknown. Although coronary
angiography has been accepted as the gold standard for
the quantification of coronary artery disease, necropsy
studies have shown that the severity of coronary artery
stenoses in angiographically “mildly diseased” arteries
may be underestimated (11–14). Furthermore, lesions in
specific locations (e.g., LMCA or proximal left anterior
descending coronary artery) are often difficult to assess
angiographically (15,16). Intravascular ultrasound
(IVUS) permits detailed, high-quality, cross-sectional
imaging of the coronary arteries in vivo. The normal
coronary artery architecture, the major components of the
atherosclerotic plaque and the changes that occur in
coronary arterial dimensions and anatomy with the ath-
erosclerotic disease process can be studied in vivo in a
manner otherwise not possible (17–30). The purposes of
this study were: 1) to correlate angiographic and IVUS
findings in LMCA disease, and 2) to identify the
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predictors of coronary events at one year in patients with
LMCA stenoses.
METHODS
Patient population. From November 5, 1991 to December
31, 1997, 355 patients underwent angiographic and IVUS
evaluation of the LMCA. These patients had ischemic
symptoms before diagnostic angiography and were referred
because the angiographic assessment of LMCA lesion
severity was inconclusive. Of this group, 233 patients
underwent LMCA-related revascularization procedures dis-
ease after IVUS evaluation, and 122 did not have catheter-
based or surgical intervention. This represents our entire
cohort of patients with suspected LMCA disease who were
studied specifically to quantify its severity. Three of the 122
patients were advised to undergo bypass graft surgery, but
refused; they were included in the current analysis. In the
current study population there were 82 men and 40 women
with a mean patient age of 63 6 10 years (range 32 to 92).
Quantitative coronary angiography (QCA) analysis. An-
giograms of the LMCA, all major epicardial vessels (left
anterior descending, left circumflex and right coronary) and
saphenous vein or arterial bypass grafts were reviewed by a
core angiographic laboratory that had no knowledge of the
IVUS or clinical findings. Quantitative coronary angiogra-
phy analysis was performed by use of a computer-assisted,
automated edge-detection algorithm (Cardiovascular Mea-
surement System, CMS-GFT, MEDIS, Leiden, The
Netherlands). With the outer diameter of the contrast-filled
catheter as the calibration standard, the minimum lumen
diameter (MLD) in diastole was measured from orthogonal
projections and the results from the “worst” view were
recorded. The reference segment diameter was averaged
from 5-mm long angiographically normal segments proxi-
mal to the lesion; when a normal proximal segment could
not be identified (e.g., ostial lesion location), a distal
angiographically normal segment was analyzed. Target le-
sion location was designated as ostial, proximal, mid or
distal. Ostial lesions were those lesions that began within
3 mm of the LMCA ostium. Lesion location was proximal
in 15%, mid in 10%, distal in 52% and ostial in 21%.
Angiograms were assessed to determine the number of
untreated vessels and treated vessels that were present in
addition to the LMCA stenosis. An untreated diseased
vessel was defined as any major epicardial vessel or bypass
graft with .50% DS narrowing that was not treated.
Thirty-nine of the 122 study patients had 56 vessels
containing an angiographic stenosis .50% DS that were
not treated. A treated diseased vessel was defined as any
major epicardial vessel or bypass graft with .50% DS
narrowing that was treated. Sixty-two of the 122 study
patients had an interventional procedure of 91 stenoses in a
major epicardial vessels 24 left anterior descending, 26 left
circumflex, 23 right coronary arteries and 18 bypass grafts.
IVUS imaging protocol. Operators were not blinded to
the ultrasound images and used the information to make
indication decisions regarding the necessity of in-hospital
coronary artery bypass graft (CABG) or catheter-based
intervention. Intravascular ultrasound imaging was per-
formed after administration of 0.2 mg intracoronary nitro-
glycerin.
Studies were performed using one of three commercially
available systems. The first (CVIS/InterTherapy Inc., San
Jose, California) incorporated a single-element 25-MHz
transducer and an angled mirror mounted on the tip of a
flexible shaft that was rotated at 1,800 rpm within a 3.9F
short monorail polyethylene imaging sheath to form planar
cross-sectional images in real time; with this system, the
transducer was withdrawn automatically at 0.5 mm/s to
perform the imaging sequence. The second (Hewlett-
Packard, Andover, Massachusetts, and Boston Scientific
Corporation, Watertown, Massachusetts) incorporated a
single-element 30-MHz beveled transducer rotated at
1,800 rpm within a 3.5F short monorail imaging catheter;
with this system, the catheter was advanced or withdrawn
manually with fluoroscopy guidance to perform the imaging
sequence. The third (Cardiovascular Imaging Systems/
Boston Scientific Corporation, San Jose, California) used a
single-element beveled transducer mounted on the end of a
flexible shaft and rotated at 1,800 rpm within either a 2.9F
long monorail/common distal lumen imaging sheath or
within a 3.2F short monorail imaging sheath. With this
system, the transducer was also withdrawn automatically at
0.5 mm/s to perform the imaging sequence. The use of a
motorized transducer pullback device and sheath-based
imaging catheters permitted the transducer to move at the
same speed as the proximal end of the imaging core. The
IVUS catheter was advanced approximately 10 mm distal to
the lesion, the video recorder turned on, the transducer
pullback device activated or manual pullback initiated and
Abbreviations and Acronyms
AS 5 area stenosis
CABG 5 coronary artery bypass graft
CASS 5 Coronary Artery Surgery Study
CSA 5 cross-sectional area
CSN 5 cross-sectional narrowing
DS 5 diameter stenosis
ECSS 5 European Coronary Surgical Study
EEM 5 external elastic membrane
IVUS 5 intravascular ultrasound
LMCA 5 left main coronary artery
MI 5 myocardial infarction
MLD 5 minimum lumen diameter
PTCA 5 percutaneous transluminal coronary
angioplasty
P&M 5 plaque & media
QCA 5 quantitative coronary angiography
VA 5 Veterans Administration Cooperative Study
of Coronary Artery Bypass Surgery
708 Abizaid et al. JACC Vol. 34, No. 3, 1999
IVUS and Left Main Coronary Disease September 1999:707–15
the entire artery imaged retrograde to the aorto-ostial
junction. Intravascular ultrasound studies were recorded on
0.5 in. high-resolution super VHS tape for off-line analysis.
Qualitative and quantitative IVUS analysis. Validation
of normal coronary anatomy, plaque composition and mea-
surements of external elastic membrane (EEM) cross-
sectional area (CSA), lumen CSA and plaque plus media
(P&M) CSA by IVUS have been reported previously
(31–35). The EEM CSA, the area encompassed by the
ultrasonic media-adventitia border, is measured by tracing
the leading edge of the adventitia; this has been shown to be
a reproducible measure of total arterial CSA. The lesion site
was the image slice with the smallest lumen CSA; among
image slices with the same small lumen CSA, the one with
the largest EEM and P&M CSA was selected. If the
atherosclerotic plaque was “packed” around the catheter,
then the lumen was assumed to be the physical (not
acoustical) size of the catheter. Because IVUS cannot
measure media thickness accurately, P&M was used as a
measure of plaque. Cross-sectional narrowing (CSN) has
also been called the plaque burden or the percent plaque
area. The reference segments were the most visually normal
LMCA cross sections within 5 mm proximal and distal to
the lesion; a distal reference was used for ostial lesions.
Plaque composition was assessed visually. Calcium was
brighter than the reference adventitia with shadowing of
deeper arterial structures; the arc of calcium was measured
with a protractor centered on the lumen. Hyperechoic,
noncalcified plaque was as bright or brighter than the
adventitia without shadowing. Hypoechoic plaque was less
bright compared with the adventitia.
Using computer planimetry (TapeMeasure, Indec Sys-
tems, Mountain View, California), the target lesion and
references segments were analyzed quantitatively as follows:
1) EEM CSA (mm2), 2) lumen CSA (mm2), 3) maximum
and minimum lumen diameters (mm), 4) P&M CSA
(mm2) equal to EEM CSA minus lumen CSA, 5) eccen-
tricity index equal to maximum divided by minimum P&M
thickness and 6) CSN equal to P&M CSA divided by the
EEM CSA.
The target lesion was compared with the reference
segment. The area stenosis (AS) was calculated as follows:
~mean reference lumen CSA 2 lesion lumen CSA! 3 100
mean reference lumen CSA
Clinical data and definitions. Baseline demographics and
in-hospital complications were confirmed by hospital chart
review. Prior myocardial infarction occurred .6 weeks
before the study. A history of coronary artery bypass surgery
and percutaneous transluminal coronary angioplasty
(PTCA) were recorded. Risk factors for coronary artery
disease included diabetes mellitus (oral agent or insulin
treated), hypertension (medication treated only) and hyper-
cholesterolemia (medication treated or a measured
.240 mg/dl). Clinical demographics of the 122 patients
were as follows: 45% had a history of myocardial infarction,
32% had previous bypass surgery, 46% had unstable angina,
34% had previous PTCA, 26% had diabetes mellitus, 58%
had hypertension and 68% had hypercholesterolemia.
Follow-up information was obtained by serial telephone
interviews 1, 3, 6 and 12 months following the diagnostic
catheterization. All events during this one-year period were
source documented. Cardiac events at follow-up interviews
that were tabulated included cardiac death, myocardial
infarction and PTCA or CABG related to the LMCA.
Statistical analysis. Statistical analysis was performed us-
ing StatView 4.5 (Abacus Concepts, Berkeley, California)
or SAS (Statistical Analysis Systems, SAS Institute Inc.,
Cary, North Carolina). Continuous data were presented as
mean value 6 1 SD; comparisons are performed using
unpaired Student t test. Categorical data are presented as
frequencies; comparisons were performed using chi-square
statistics or Fisher’s exact test. A p-value ,0.05 was
considered significant.
Logistic regression analysis was used to identify the
independent predictors of late cardiac events. Univariate
predictors of cardiac events at follow-up procedures with a
p-value ,0.05 were entered into the multivariate model.
RESULTS
Correlation of angiographic versus IVUS results. In the
overall cohort, reference lumen diameter measured 3.91 6
0.76 mm, MLD measured 2.26 6 0.82 mm and the DS
measured 42 6 16%. Overall, the QCA reference diameter
correlated moderately with IVUS reference diameter
(4.25 6 0.78 mm, r 5 0.492, p 5 0.0001). The lesion site
MLD by QCA correlated less well with IVUS (2.81 6
0.82 mm, r 5 0.364, p 5 0.0005). These results and a
clinical example are shown in Figures 1 and 2. In addition,
the DS (35 6 15%) by IVUS did not correlate at all with
QCA (r 5 0.106).
One-year cardiac events. Follow-up data were available in
98% of the 122 patients, in a mean follow-up time of 11.7
months.
There were four (3%) cardiac deaths (mean time of 4.4
months). Two patients died after complications of bypass
surgery, one patient had sudden cardiac death and one
patient with severe LMCA and triple vessel disease refused
bypass surgery and died one month after diagnostic cathe-
terization. There were no patients with myocardial infarc-
tion at the time of follow-up procedures.
During the 12-month follow up period, three (2%)
patients had PTCA of the LMCA (mean time of 5.8
months): three Palmaz-Schatz stents (two in a protected
LMCA and one in an unprotected LMCA). Eleven (9%)
patients had bypass surgery (mean time of 8.3 months).
Clinical predictors of cardiac events (Table 1). In this
patient cohort, age, male gender, prior myocardial infarc-
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tion, previous CABG, previous PTCA, hypertension and
hypercholesterolemia were not significant univariate predic-
tors of cardiac events at follow-up. The only clinical
predictor of cardiac events was the presence of diabetes
mellitus; 25% of the diabetic patients versus 11% of the
non-diabetics had an event (p 5 0.029).
Angiographic predictors of cardiac events (Table 2).
There was a strong trend toward smaller reference segment
LMCA diameters in patients with cardiac events (3.63 6
0.81 mm vs. 3.98 6 0.74 mm with no events, p 5 0.059).
It is important to note that the QCA MLD and DS were
not univariate predictors of events; 10% of patients with
DS , 50%, 18% of patients with DS 50% to 70%, and 8%
of patients with DS . 70% had events. The presence of any
untreated or treated vessel was a predictor of cardiac events
at follow-up.
IVUS predictors of cardiac events (Table 3). Plaque
composition did not predict events at follow up. Plaque
composition was as follows: 42% dominantly hyperechoic,
38% dominantly hypoechoic and 20% a combination of
both. None of the plaques was dominantly calcific; the arc of
calcium measured 66° 6 107°.
Patients with events had smaller lesion site lumen CSA
(6.8 6 4.4 vs. 10 6 5.3 mm2), maximum lumen diameter
(3.07 6 0.77 vs. 3.85 6 0.86 mm) and MLD (2.30 6 0.69
vs. 2.94 6 0.81 mm); larger lesion site P&M CSA (15.7 6
5.2 vs. 11.9 6 5.9 mm2) and CSN (70 6 14 vs. 53 6 18%);
larger reference segment CSN (42 6 13 vs. 35 6 12%); and
larger AS (52 6 21 vs. 34 6 20%). For the entire cohort, the
event rate was 60% for an IVUS MLD , 2.0 mm, 24% for
an MLD 2.0 to 2.5, 16% for an MLD 2.5 to 3.0 mm and
3% for an MLD . 3.0 mm.
Multivariate predictors of cardiac events (Table 4). All
clinical, angiographic and IVUS parameters with p , 0.05
were tested in the multivariate model. These included
the following: diabetes mellitus, presence of untreated or
treated vessels, IVUS reference CSN, IVUS lesion site
lumen CSA, maximum lumen diameter, MLD, P&M
CSA, CSA and IVUS AS. Using multivariate logistic
regression analysis, the presence of diabetes mellitus, the
presence of an untreated vessel and IVUS MLD were found
to be the independent predictors of cardiac events at follow
up. The probability curves of any cardiac event are shown in
Figure 3.
DISCUSSION
The current study of LMCA disease showed the following:
1) there was a poor correlation between QCA and IVUS in
the assessment of reference segment and lesion site lumen
dimensions, 2) the one year event (death, myocardial infarc-
tion or need for revascularization) rate in patients with
IVUS-guided deferred treatment of LMCA stenoses was
14% with ,2% having procedure unrelated deaths and 3)
there were three distinct predictors of these cardiac events:
diabetes, a major epicardial vessel or bypass graft with a
QCA DS $50% that was left untreated and LMCA lesion
site MLD measured by IVUS.
Limitations of angiography in assessing LMCA disease.
The angiographic assessment of LMCA stenoses has been
compared with necropsy or IVUS. Coronary angiography
underestimates stenosis severity most markedly in vessels
with 50% to 75% arterial area narrowing at necropsy
(13,15,16,36). Hermiller et al. showed that a very high
percentage (89%) of patients with angiographically normal
LMCA had disease by IVUS (27). These findings were
confirmed in studies by Yamagishi, Gerber and Ge
(25,28,30).
Hermiller also reported no correlation between IVUS and
QCA lumen dimensions in patients with angiographically
detectable LMCA disease (27). In the current study, there
Figure 2. This case example illustrates the discrepancy between
angiographic and IVUS evaluation of LMCA disease. This patient
underwent bypass surgery for ostial LMCA disease (black arrow).
After the bypass grafts closed, he was referred for IVUS study. By
QCA, the ostial LMCA stenosis MLD measured 1.32 mm. By
IVUS, there was mild diffuse atherosclerosis (white arrows), no
significant plaque burden and an MLD of 3.5 mm. LMCA 5 left
main coronary artery. Other abbreviations as in Figure 1.
Figure 1. The correlation between the lesion site MLD by QCA
(2.26 6 0.82 mm) and IVUS (2.81 6 0.82 mm was r 5 0.364, p 5
0.0005 [Panel A]). The correlation between the QCA reference
diameter (3.91 6 0.76 mm) and IVUS (4.25 6 0.78 mm) was r 5
0.492, p 5 0.0001 (Panel B). IVUS 5 intravascular ultrasound;
MLD 5 minimum lumen diameter; QCA 5 quantitative coro-
nary angiography.
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was a poor correlation in measurement of MLD by IVUS
and QCA and QCA overestimated the degree of LMCA
narrowing in some patients. Ultimately, the clinical value of
any quantitative assessment is its ability to predict patient
outcomes and its reproducibility. The QCA MLD and DS
were similar in patients with and without cardiac events at
one year. Conversely, numerous IVUS parameters were
significantly different in patients with and without events,
and the IVUS MLD was the only independent quantitative
predictor of late events.
The main reasons for the discrepancy between angiogra-
phy and necropsy or IVUS appear to be the following: 1)
diffuse atherosclerotic involvement affects the DS calcula-
tion because of the lack of a normal reference segment, 2) a
short LMCA also makes identification of a normal refer-
ence segment difficult, 3) there is compensatory enlarge-
ment (positive remodeling) of the vessel as plaque burden
increases to preserve lumen size as shown by Glagov et al.
(37), 4) there may be unique geometric issues in LMCA
disease because the correlation between angiography and
necropsy or IVUS appears to be somewhat better in non-
LMCA stenoses (19,20) and 5) there is significant inter-
and intraobserver variability in the angiographic assessment
of LMCA disease (14,38–40). Interpretations of a single
lesion have varied from 0% to 80% stenosis, and interob-
server disagreement has been as high as 20% (41,42). Fisher
et al. (14) reported on 810 arteriograms from the Coronary
Artery Surgery Study (CASS) that were independently read
by two angiographers; measurements of the LMCA were
the least reproducible of any coronary arterial segment.
When one angiographer reported a stenosis of .50%, a
second angiographer reported no lesion 19% of the time.
Cameron et al. (43) tested the reliability of the angiographic
assessment of the LMCA using 106 coronary cineangio-
grams also from CASS; in three separate readings, there was
only a 41% to 59% agreement on stenosis severity although
there was an 80% agreement on whether the lesion was
greater or less than 50% . These studies have all shown that
the discrepancy between angiography and necropsy or IVUS
and the interobserver variability in angiographic assessment
of LMCA stenoses have been most significant in patients
with moderate stenoses (13,15,16,36,44). The patients in
the current study had a mean QCA DS of 42% and a mean
IVUS CSN of 57%, indicative of moderate disease.






(n 5 18) p
Age (yr) 63 6 10 62 6 10 63 6 11 0.76
Male gender, n (%) 82 (67) 68 (65) 14 (78) 0.19
Prior MI, n (%) 55 (45) 45 (43) 10 (58) 0.24
Prior bypass surgery, n (%) 39 (32) 33 (32) 6 (33) 0.74
Prior intervention, n (%) 41 (34) 36 (35) 5 (28) 0.37
Unstable angina, n (%) 54 (46) 44 (42) 10 (58) 0.26
Diabetes, n (%) 32 (26) 24 (23) 8 (44) 0.029
Hypertension, n (%) 71 (58) 60 (58) 11 (61) 0.87
Hypercholesterolemia, n (%) 83 (68) 71 (68) 12 (66) 0.74
Body surface area (M2) 1.93 6 0.21 1.93 6 0.23 1.91 6 0.16 0.74






(n 5 18) p
Reference (mm) 3.91 6 0.76 3.98 6 0.74 3.63 6 0.81 0.0594
Minimum lumen diameter (mm) 2.26 6 0.82 2.32 6 0.83 2.00 6 0.72 0.1086
Diameter stenosis (%) 42 6 16 42 6 17 44 6 16 0.47
Ostial lesion location (%) 21 20 22 0.90
Left ventricular ejection fraction (%) 48 6 11 48 6 12 50 6 7 0.58
Any untreated vessel, n (%) 39 (32) 27 (26) 12 (67) 0.007
1 untreated vessel 24 (62) 17 (63) 7 (59)
2 untreated vessels 13 (33) 9 (33) 4 (33)
3 untreated vessels 2 (5) 1 (4) 1 (8)
Any treated vessel, n (%) 63 (52) 48 (46) 15 (83) 0.014
1 treated vessel 40 (64) 34 (71) 6 (40)
2 treated vessels 15 (25) 10 (22) 5 (33)
3 treated vessels 7 (11) 3 (7) 4 (27)
Any treated or untreated vessel, n (%) 83 (68) 69 (66) 14 (78) 0.051
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Natural history of LMCA disease. The presence of
LMCA disease has important prognostic and therapeutic
implications (1–10). In general, surgical treatment improves
survival significantly (2,3,5,8,9,45–48). Recently, the CASS
Registry reported the longest follow-up period of the largest
cohort of patients (n 5 1484) with .50% LMCA angio-
graphic DS (49). The 15-year cumulative survival estimates
were 37% for surgery compared with 27% for medical
therapy. Median survival in the surgical group was 13.3
years, compared with only 6.6 years in the medical group
(p , 0.0001). However, subgroup analysis showed that the
prognosis of medically treated patients was not always poor.
Median survival was not prolonged by surgery in patients
with: 1) LMCA stenoses ,60%, 2) normal left ventricular
function and 3) a nonstenotic (,70%) right coronary artery.
Two other randomized trials comparing surgical versus
medical therapy in patients with significant LMCA stenosis
were the Veterans Administration Cooperative Study of
Coronary Artery Bypass Surgery (VA) and the European
Coronary Surgical Study (ECSS) (50,51,52). The VA
Cooperative Study showed that most of the mortality in
medically treated patients occurred within the first year of
diagnosis. However, these findings were contradicted by
ECSS, which reported one-, two- and three-year survival
rates of 95%, 88% and 82% in patients treated medically.
Figure 3. The probability of cardiac events at one year was
quantitatively related to the IVUS MLD (mm). At the same
MLD, the frequency of events was highest in patients with
diabetes and at least one untreated vessel with a DS . 50%;
intermediate in patients with diabetes or at least one untreated
vessel with a DS . 50%, but not both; and lowest in patients with
neither diabetes nor an untreated vessel with a DS . 50%. DS 5
diameter stenosis. All other abbreviations as in Figure 1.






(n 5 18) p
Reference
EEM CSA (mm2) 23.3 6 6.9 23.3 6 7.1 23.2 6 6.3 0.96
Lumen CSA (mm2) 14.7 6 5.7 15.0 6 5.6 13.4 6 6.0 0.31
P&M CSA (mm2) 8.6 6 4.1 8.3 6 4.1 9.7 6 3.9 0.18
CSN (%) 37 6 13 35 6 12 42 6 13 0.0418
Lesion site
EEM CSA (mm2) 22.0 6 6.9 21.9 6 7.0 22.5 6 7.0 0.72
Lumen CSA (mm2) 9.3 6 5.3 10.0 6 5.3 6.8 6 4.4 0.0127
Maximum lumen diameter (mm) 3.70 6 0.90 3.85 6 0.86 3.07 6 0.77 0.0003
MLD (mm) 2.81 6 0.82 2.94 6 0.81 2.30 6 0.69 0.0012
P&M CSA (mm2) 12.7 6 5.9 11.9 6 5.9 15.7 6 5.2 0.0077
Arc of calcium (°) 66 6 107 62 6 108 82 6 103 0.47
Eccentricity index 12.7 6 15.1 13.1 6 15.4 11.5 6 14.8 0.69
CSN (%) 57 6 18 53 6 18 70 6 14 0.0002
AS (%) 38 6 22 34 6 20 52 6 21 0.0007
AS 5 area stenosis; CSA 5 cross-sectional area; CSN 5 cross-sectional narrowing; EEM 5 external elastic membrane; P&M 5 plaque & media; MLD 5 minimum lumen
diameter.
Table 4. Multivariate Predictors of Cardiac Events at
Follow-up Procedures
OR 95% CI p
Diabetes mellitus 6.32 1.82–22.04 0.004
Any untreated vessel 3.80 1.08–13.39 0.037
IVUS lesion site minimum
lumen diameter
0.17 0.05–0.59 0.005
IVUS 5 intravascular ultrasound.
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Patients in the ECSS differed from those in the VA study
because all patients were ,65-years-old with good left
ventricular function. Findings similar to ECSS were seen in
a study by Lim et al. (53).
The severity of the LMCA stenosis may have prognostic
importance. Conley et al. (3) reported that patients with an
LMCA stenosis of 50% to 70% had a three-year survival of
66%, whereas patients with a stenosis .70% had only a 41%
three-year survival rate. In the current study, patients with
mild LMCA disease had a survival rate of 97% and an
event-free survival rate of 86% at one year. Although these
were patients with moderate disease, the IVUS MLD was
an independent predictor of cardiac events confirming the
prognostic importance of LMCA disease severity. It is
important to note that the QCA MLD and DS were similar
in patients with and without events, indicating the limita-
tions of angiography in prognosticating LMCA disease.
The presence of a significant stenoses in an untreated
vessel, a predictor of cardiac events in the current study, has
also been shown by others to be important. Yamagishi et al.
(25) reported that the LMCA plaque burden was greater in
the presence of a significant stenosis (.50% DS) in at least
one of the three major coronary arteries. Shimazu et al. (54)
also reported indirect evidence for increased severity of
LMCA disease in multivessel coronary artery disease by
showing decreased LMCA compliance with the develop-
ment of stenoses in another vessels. Bruschke et al. (4),
Campeau et al. (5) and DeMots et al. (55) demonstrated
that the poor prognosis of patients with LMCA disease is
largely related to the high frequency of coexisting coronary
artery disease.
Diabetes mellitus as a predictor of cardiac events. In the
current study, diabetes mellitus was an independent predic-
tor of cardiac events. For every given LMCA lumen
diameter, the risk of events was higher if the patient was
diabetic.
Clinical and epidemiologic studies have shown that
coronary artery disease is more aggressive in patients with
diabetes. Diabetic patients are thought to have more diffuse
disease, four to five times the mortality rate and worse
outcomes after coronary interventions (56–60). Several
factors have been found to promote accelerated atheroscle-
rosis in diabetics. These factors include increased oxidation
level of low density lipoproteins, non-enzymatic glycation of
vessel wall proteins, accelerated smooth muscle cell prolif-
eration and migration, hyperinsulinemia, impaired fibrino-
lysis and increase in platelet aggregation (61–67). These
processes together may cause an increase in cholesterol
synthesis, endothelial dysfunction, hyperplastic vasculopa-
thy, microvascular disease and a prothrombotic state, hall-
marks of diabetic vascular disease (61–67).
Other predictors of cardiac events. In the CASS study,
left ventricular systolic function was found to be a predictor
of 15-year survival in both surgically and medically treated
patients (49). However, advanced age and severe angina
pectoris were predictors of survival only in the medical
group.
In a study of 163 medically treated patients with 50% or
greater LMCA stenosis, Conley et al. (3) found that the
following predicted one-year survival: history of congestive
heart failure, angina at rest, cardiomegaly on chest X-ray,
ST-T wave changes on the resting electrocardiogram and
abnormal left ventricular contraction pattern. Other studies
have substantiated the importance of left ventricular func-
tion, electrocardiograph abnormalities and concomitant
multivessel disease, especially in medically treated patients
(9,10,53).
Study limitations. Unlike most angiographic studies of the
natural history of coronary artery disease (e.g., CASS), the
current report was primarily a study of patients referred for
diagnostic evaluation of LMCA disease. These patients
typically had ambiguous angiograms, potentially leading to
both the exaggerated discrepancy between QCA and IVUS
and the lack of the independent predictive power of QCA
measurements. This may have introduced a bias into the
results. Furthermore, this patient population appears to be
very stable which may limit the generalizability of these
findings.
Plaque composition by IVUS was not a predictor of
cardiac events. Current IVUS morphologic analysis was not
able to determine lipid content of the atherosclerotic dis-
ease, and the propensity of plaques to become unstable and
cause coronary events is directly related to the amount of
extracellular lipid. In the future, raw radiofrequency signal
analysis may help identify stable versus unstable lesions.
However, the nonsignificant trend for larger arcs of calcium
and smaller eccentricity indexes in LMCA lesions with
subsequent events suggests that they contained more mature
plaques.
The IVUS report, itself, could have biased the patients’
decisions concerning revascularization, especially in patients
with smaller lumen areas, diabetes and disease in other
epicardial vessels. However, the nonprocedure-related mor-
tality in this cohort of patients with IVUS-guided deferred
treatment of LMCA stenoses was ,2%, too low to identify
specific predictors.
Although these patients all had symptoms indicating
significant coronary artery disease, few had noninvasive
testing.
Conclusions and clinical implications. In selected pa-
tients as assessed by IVUS, the natural history of moderate
LMCA disease has a one-year event rate of only 14% (3%
death and 11% need of any revascularization). Intravascular
ultrasound measurement of MLD was the most important
quantitative predictor of cardiac events. For any given
MLD, the event rate was exaggerated in the presence of
diabetes mellitus or an untreated lesion in a major vessel
.50% DS. Intravascular ultrasound should be considered in
the assessment of patients with angiographically ambiguous
or inconclusive LMCA disease.
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